Related Experiment Video
Updated: Jul 11, 2026

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis
Published on: December 1, 2023
Hashimot's encephalopathy-response to intravenous immunoglobulin
E Wirkowski1, R B Libman, M Batash
1Department of Neurology, Long Island Jewish Medical Center, New Hyde Park, NY, USA.
Background:
Hashimoto's encephalopathy is an unusual brain disorder consisting of focal and diffuse cerebral dysfunction that may present in a stroke-like fashion. Treatment has consisted of steroids and immunosuppression. Treatment with a potentially less toxic modality such as intravenous immunoglobulin (IVIG), if found to be effective, might offer an alternative approach to these patients.
Case Description:
We present an 82-year-old woman who developed headache, changes in mental status, and multifocal neurological deficits. Investigation revealed significantly elevated titers of antithyroid antibodies. Treatment with prednisone and methotrexate was unsuccessful. Treatment with monthly courses of IVIG resulted in marked clinical improvement.
Conclusion:
Hashimoto's encephalopathy may be more common than is generally recognized. A trial of IVIG should be considered for patients with this devastating condition.
Related Concept Videos
Encephalitis ll: Pathophysiology
Hepatic Encephalopathy
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Graves' Disease I: Introduction
Encephalitis l: Introduction
Graves Disease II: Pathophysiology
